JP Stock MarketDetailed Quotes

4552 JCR Pharmaceuticals

Watchlist
  • 615
  • 00.00%
20min DelayTrading Jul 4 09:55 JST
76.75BMarket Cap14.00P/E (Static)

JCR Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Total revenue
24.83%42.87B
19.69%9.15B
-15.02%9.45B
125.34%13.46B
12.51%10.81B
-32.77%34.34B
-29.27%7.65B
-6.49%11.12B
-67.82%5.98B
-2.11%9.61B
Cost of revenue
30.77%11.62B
60.90%3.2B
23.22%2.54B
32.32%2.52B
14.66%3.36B
-15.06%8.89B
-45.34%1.99B
-11.88%2.06B
-19.40%1.9B
38.09%2.93B
Gross profit
22.76%31.25B
5.23%5.96B
-23.73%6.9B
168.81%10.95B
11.59%7.45B
-37.33%25.46B
-21.13%5.66B
-5.17%9.05B
-74.88%4.07B
-13.22%6.67B
Operating expense
15.82%23.72B
10.57%6.23B
23.72%5.99B
25.72%6.11B
4.73%5.38B
-1.00%20.48B
0.68%5.64B
0.31%4.84B
-12.44%4.86B
9.18%5.14B
Operating profit
51.37%7.53B
-1,304.35%-277M
-78.35%911M
710.87%4.83B
34.51%2.07B
-75.04%4.98B
-98.54%23M
-10.79%4.21B
-107.42%-791M
-48.53%1.54B
Net non-operating interest income (expenses)
327.27%25M
57.14%22M
122.22%2M
385.71%20M
-111.11%-19M
71.05%-11M
240.00%14M
0.00%-9M
30.00%-7M
0.00%-9M
Non-operating interest income
236.36%111M
80.00%45M
733.33%25M
925.00%41M
--0
371.43%33M
1,150.00%25M
50.00%3M
100.00%4M
0.00%1M
Non-operating interest expense
95.45%86M
109.09%23M
91.67%23M
90.91%21M
90.00%19M
-2.22%44M
-8.33%11M
9.09%12M
-8.33%11M
0.00%10M
Net investment income
91.08%793M
585.00%411M
36.29%-302M
-31.75%187M
-10.45%497M
-28.32%415M
-73.33%60M
-286.61%-474M
234.15%274M
2,983.33%555M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
0
10M
Income from associates and other participating interests
-15,471.43%-1.09B
-2,957.14%-214M
-369M
-210M
-297M
-7M
-7M
0
0
0
Special income (charges)
-25.00%-20M
60.00%-2M
-550.00%-13M
44.44%-5M
0
98.55%-16M
95.28%-5M
-2M
-800.00%-9M
0
Less:Other special charges
25.00%20M
-60.00%2M
550.00%13M
----
----
-98.55%16M
-95.28%5M
--2M
----
----
Other non-operating income (expenses)
-88.64%5M
-275.68%-65M
625.00%21M
36M
13M
15.79%44M
1,025.00%37M
-112.50%-4M
Income before tax
33.85%7.24B
-196.21%-127M
-93.25%251M
1,029.25%4.86B
8.50%2.26B
-72.11%5.41B
-92.15%132M
-25.50%3.72B
-104.87%-523M
4.20%2.08B
Income tax
5.05%1.71B
-602.86%-492M
-69.51%339M
1,028.46%1.21B
-8.42%653M
-66.74%1.63B
-176.92%-70M
-14.79%1.11B
-104.29%-130M
54.00%713M
Net income
46.18%5.54B
79.31%364M
-103.37%-88M
1,029.52%3.65B
17.38%1.61B
-73.91%3.79B
-87.24%203M
-29.28%2.61B
-105.10%-393M
-10.87%1.37B
Net income continuous operations
46.21%5.54B
80.69%365M
-103.37%-88M
1,029.52%3.65B
17.30%1.61B
-73.92%3.79B
-87.30%202M
-29.28%2.61B
-105.10%-393M
-10.81%1.37B
Noncontrolling interests
100.00%28M
1,800.00%17M
300.00%4M
-35.71%9M
-2M
40.00%14M
-120.00%-1M
0.00%1M
1,300.00%14M
0
Net income attributable to the company
46.00%5.51B
70.10%347M
-103.57%-93M
997.29%3.64B
17.69%1.61B
-74.00%3.77B
-87.14%204M
-29.32%2.61B
-105.27%-406M
-10.70%1.37B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
46.00%5.51B
70.10%347M
-103.57%-93M
997.29%3.64B
17.69%1.61B
-74.00%3.77B
-87.14%204M
-29.32%2.61B
-105.27%-406M
-10.70%1.37B
Gross dividend payment
Basic earnings per share
45.40%44.13
71.60%2.78
-103.58%-0.75
987.23%29.19
16.73%12.91
-74.12%30.35
-87.35%1.62
-29.64%20.96
-105.28%-3.29
-10.81%11.06
Diluted earnings per share
45.33%43.92
71.43%2.76
-103.59%-0.75
982.98%29.05
16.61%12.85
-74.13%30.22
-87.39%1.61
-29.66%20.87
-105.30%-3.29
-10.70%11.02
Dividend per share
0.00%20
0.00%10
0
0.00%10
0
0.00%20
0.00%10
0
0.00%10
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Total revenue 24.83%42.87B19.69%9.15B-15.02%9.45B125.34%13.46B12.51%10.81B-32.77%34.34B-29.27%7.65B-6.49%11.12B-67.82%5.98B-2.11%9.61B
Cost of revenue 30.77%11.62B60.90%3.2B23.22%2.54B32.32%2.52B14.66%3.36B-15.06%8.89B-45.34%1.99B-11.88%2.06B-19.40%1.9B38.09%2.93B
Gross profit 22.76%31.25B5.23%5.96B-23.73%6.9B168.81%10.95B11.59%7.45B-37.33%25.46B-21.13%5.66B-5.17%9.05B-74.88%4.07B-13.22%6.67B
Operating expense 15.82%23.72B10.57%6.23B23.72%5.99B25.72%6.11B4.73%5.38B-1.00%20.48B0.68%5.64B0.31%4.84B-12.44%4.86B9.18%5.14B
Operating profit 51.37%7.53B-1,304.35%-277M-78.35%911M710.87%4.83B34.51%2.07B-75.04%4.98B-98.54%23M-10.79%4.21B-107.42%-791M-48.53%1.54B
Net non-operating interest income (expenses) 327.27%25M57.14%22M122.22%2M385.71%20M-111.11%-19M71.05%-11M240.00%14M0.00%-9M30.00%-7M0.00%-9M
Non-operating interest income 236.36%111M80.00%45M733.33%25M925.00%41M--0371.43%33M1,150.00%25M50.00%3M100.00%4M0.00%1M
Non-operating interest expense 95.45%86M109.09%23M91.67%23M90.91%21M90.00%19M-2.22%44M-8.33%11M9.09%12M-8.33%11M0.00%10M
Net investment income 91.08%793M585.00%411M36.29%-302M-31.75%187M-10.45%497M-28.32%415M-73.33%60M-286.61%-474M234.15%274M2,983.33%555M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 010M
Income from associates and other participating interests -15,471.43%-1.09B-2,957.14%-214M-369M-210M-297M-7M-7M000
Special income (charges) -25.00%-20M60.00%-2M-550.00%-13M44.44%-5M098.55%-16M95.28%-5M-2M-800.00%-9M0
Less:Other special charges 25.00%20M-60.00%2M550.00%13M---------98.55%16M-95.28%5M--2M--------
Other non-operating income (expenses) -88.64%5M-275.68%-65M625.00%21M36M13M15.79%44M1,025.00%37M-112.50%-4M
Income before tax 33.85%7.24B-196.21%-127M-93.25%251M1,029.25%4.86B8.50%2.26B-72.11%5.41B-92.15%132M-25.50%3.72B-104.87%-523M4.20%2.08B
Income tax 5.05%1.71B-602.86%-492M-69.51%339M1,028.46%1.21B-8.42%653M-66.74%1.63B-176.92%-70M-14.79%1.11B-104.29%-130M54.00%713M
Net income 46.18%5.54B79.31%364M-103.37%-88M1,029.52%3.65B17.38%1.61B-73.91%3.79B-87.24%203M-29.28%2.61B-105.10%-393M-10.87%1.37B
Net income continuous operations 46.21%5.54B80.69%365M-103.37%-88M1,029.52%3.65B17.30%1.61B-73.92%3.79B-87.30%202M-29.28%2.61B-105.10%-393M-10.81%1.37B
Noncontrolling interests 100.00%28M1,800.00%17M300.00%4M-35.71%9M-2M40.00%14M-120.00%-1M0.00%1M1,300.00%14M0
Net income attributable to the company 46.00%5.51B70.10%347M-103.57%-93M997.29%3.64B17.69%1.61B-74.00%3.77B-87.14%204M-29.32%2.61B-105.27%-406M-10.70%1.37B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 46.00%5.51B70.10%347M-103.57%-93M997.29%3.64B17.69%1.61B-74.00%3.77B-87.14%204M-29.32%2.61B-105.27%-406M-10.70%1.37B
Gross dividend payment
Basic earnings per share 45.40%44.1371.60%2.78-103.58%-0.75987.23%29.1916.73%12.91-74.12%30.35-87.35%1.62-29.64%20.96-105.28%-3.29-10.81%11.06
Diluted earnings per share 45.33%43.9271.43%2.76-103.59%-0.75982.98%29.0516.61%12.85-74.13%30.22-87.39%1.61-29.66%20.87-105.30%-3.29-10.70%11.02
Dividend per share 0.00%200.00%1000.00%1000.00%200.00%1000.00%100
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
%Chg